DMAB-anabaseine dihydrochloride
DMAB-anabaseine dihydrochloride is a selective cholinergic modulator, acting as a partial agonist at α7 nicotinic acetylcholine receptors and an antagonist at α4β2 subtypes. This pharmacological profile makes it a valuable research tool for investigating receptor function in neurobiological studies, including in vitro assays and models of cognitive and inflammatory processes.
Product Specifications
CAS Number
154149-38-9
Product Name Alternative
DMAB anabaseine dihydrochloride, DMAB-anabaseine, DMABanabaseine dihydrochloride, DMAB-anabaseine Dihydrochloride, dihydrochloride, Dihydrochloride, N, N-dimethyl-4-[ (E) - (6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene) methyl]aniline, N, N-dimethyl-4-[ (E) - (6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene) methyl]aniline; dihydrochloride, α7 nAChR, α4β2 nAChR
Field of Research
Neuroscience
Purity
99.86% (May vary between batches)
Solubility
H2O:< 36.43 mg/mL; DMSO:3.65 mg/mL (10.02 mM)
Smiles
CN (C1=CC=C (C=C1) /C=C2C (C3=CN=CC=C3) =NCCC/2) C.Cl.Cl
Molecular Formula
C19H23Cl2N3
Molecular Weight
364.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
R2031-74E-ML650 100 µL
RIP3, ID (Receptor-interacting Serine/Threonine-protein Kinase 3, RIP-like Protein Kinase 3, Receptor-interacting Protein 3, RIP-3, RIPK3) (MaxLight 650) discontinued
Sign In for Pricing
View Details 